Cycurion Inc. SEC Filings

Cycurion, Inc. reported multiple updates. The company announced it has regained compliance with Nasdaq’s minimum bid price requirement of $1.00 per share under Listing Rule 5450(a)(1), and the previously scheduled Nasdaq Hearings Panel session was canceled. Its securities will continue trading on The Nasdaq Stock Market without interruption.

Cycurion also disclosed a new contract award from a telecommunications company to deliver network deployment services supporting a federal agency modernization initiative. Additionally, the company furnished a press release with financial results for the quarter ended September 30, 2025, and its Board approved an amended and restated insider trading policy to clarify trading windows and blackout periods.

Cycurion, Inc. (CYCU) reported a new contract award. On November 5, 2025, the company announced that its subsidiary, SLG Innovation, Inc., was awarded a $1.1 million engagement to modernize legacy data systems for one of America’s largest county-level public guardian offices.

The win highlights Cycurion’s public-sector IT capabilities through SLG Innovation, focusing on updating critical government data infrastructure. The disclosure was made under an Other Events item, and the related press release was furnished as an exhibit.

Cycurion (CYCU) filed a Form 3 initial ownership report. The reporting person is a Director and disclosed no securities beneficially owned as of the event date. The filing indicates it was filed by one reporting person.

The date of the event requiring the statement was 02/14/2025. This is an administrative disclosure establishing the insider’s baseline holdings at zero.

Cycurion, Inc. announced via an Other Events update that it issued a press release unveiling a three-part cybersecurity webinar series with the National Association of County and City Health Officials (NACCHO). The series is designed to equip healthcare organizations with critical threat intelligence and defensive strategies. The press release is furnished as Exhibit 99.1. Cycurion’s securities trade on NASDAQ under CYCU and CYCUW.

Cycurion, Inc. filed an 8-K stating it was selected as an approved vendor under the Florida State Term Contract for Information Technology Staff Augmentation Services. The company disclosed this under Item 8.01 and furnished a press release as Exhibit 99.1 dated October 29, 2025. This designation allows Cycurion to be eligible for staff augmentation opportunities within Florida’s statewide IT procurement framework, as outlined in the announcement.

Cycurion, Inc. implemented a one-for-thirty reverse stock split effective October 27, 2025. The company’s common shares began trading on a split-adjusted basis on the Nasdaq Global Market under the existing ticker CYCU, with a new CUSIP 95758L305.

Every thirty issued shares were combined into one, with no change to par value or the total authorized common shares. Outstanding common shares decreased from approximately 86,533,435 to approximately 2,884,447. Fractional shares will not be issued; holders entitled to a fraction will receive cash based on the closing price on the trading day immediately before the effective date.

The company also disclosed it requested a hearing before a Nasdaq Hearings Panel to appeal a delisting determination, with the hearing scheduled for November 20, 2025.

Cycurion, Inc. approved and implemented a 1-for-30 reverse stock split of its common stock. The action becomes effective with the commencement of business on October 27, 2025, and the shares will begin trading on a split-adjusted basis on The Nasdaq Global Market under the symbol CYCU.

Every thirty issued shares will be combined into one share without changing the par value or the total number of authorized common shares. The number of outstanding common shares will be reduced from approximately 86,533,435 to approximately 2,884,447. No fractional shares will be issued; holders entitled to a fraction will receive a cash payment based on the closing price on the trading day immediately preceding the effective date. Proportionate adjustments will be made to outstanding warrants, option exercise prices and share amounts, and restricted stock awards. The new CUSIP for the common stock will be 95758L305.

Cycurion, Inc. (CYCU) reported a Nasdaq delisting determination and filed an appeal. The company received notice on October 14, 2025 that its common stock is subject to delisting from the Nasdaq Global Market after failing to regain compliance with the $1.00 bid price rule. Cycurion submitted an appeal on October 20, 2025, which stays any suspension and Form 25-NSE filing pending a panel decision, with hearings typically set 30–45 days after the request.

To address the bid-price deficiency, the board approved a 30:1 reverse stock split expected to take effect on October 27, 2025, following prior stockholder approval of a reverse-split range. The company also announced five new contracts totaling approximately $1 million, expected to add $75,000 in monthly recurring revenue. If the appeal is unsuccessful, the shares may move to the over-the-counter market, which the company notes is a more limited and less liquid trading venue and could pressure the stock price.